Recombinant E. coli for Isobutyraldehyde Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microorganisms, such as E. coli, efficiently convert aldehydes to alcohols due to robust endogenous alcohol dehydrogenase and aldehyde reductase activity, limiting the production of non-alcohol chemicals like isobutyraldehyde, which are in high demand for industrial uses.

Innovation Solution

Development of recombinant E. coli with reduced alcohol dehydrogenase and isobutyraldehyde reductase activity through targeted mutations in specific genes, combined with overexpression of 2-keto-acid decarboxylase, to produce non-alcohol chemicals from suitable carbon sources.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If E. coli with intact alcohol dehydrogenase and aldehyde reductase activity is used, then the microorganism maintains robust metabolic function and growth, but the production of aldehydes like isobutyraldehyde is limited due to efficient conversion to alcohols

Engineering Contradiction:
Improvealdehyde productionVSAvoidendogenous alcohol dehydrogenase and aldehyde reductase activity
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent applies the extraction principle by removing or reducing the harmful endogenous alcohol dehydrogenase and aldehyde reductase activities through targeted gene deletions (adhE, yqhD, adhP, eutG, yiaY, yjgB) and mutations. This extraction of specific enzymatic functions allows aldehydes to accumulate without being converted to alcohols, directly resolving the contradiction between maintaining metabolic function and achieving high aldehyde production

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs parameter changes by modifying the genetic parameters of E. coli through deletions and mutations in ADH genes, thereby changing the enzymatic activity parameters. This enables the organism to maintain growth while achieving high aldehyde titers (e.g., 12.6 g/L isobutyraldehyde) by altering the balance between aldehyde production and reduction activities

Inventive Principle:
Principle #35Parameter changes

2Productivity

If all six ADH genes (adhE, yqhD, adhP, eutG, yiaY, yjgB) are deleted to eliminate alcohol dehydrogenase activity, then isobutyraldehyde production is significantly enhanced, but the complexity of genetic engineering increases

Engineering Contradiction:
Improveisobutyraldehyde titerVSAvoidgenetic engineering complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the genetic engineering task into manageable modules: identifying individual ADH genes (adhE, yqhD, adhP, eutG, yiaY, yjgB), creating targeted deletions for each gene, and systematically characterizing the contribution of each deletion to overall alcohol dehydrogenase activity reduction. This segmented approach makes the complex six-gene deletion project systematic and reproducible

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs preliminary action by first identifying and characterizing the six major ADH genes in E. coli before performing the deletions. The systematic identification of target genes and preliminary characterization of their individual contributions to alcohol dehydrogenase activity provides a roadmap for the subsequent multi-gene deletion strategy, reducing overall engineering complexity

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The recombinant E. coli strains effectively reduce alcohol dehydrogenase and isobutyraldehyde reductase activity, enhancing the production of non-alcohol chemicals like isobutyraldehyde, improving the biosynthesis of industrially useful compounds.

Implementation Method 1

overexpression of 2-keto-acid decarboxylase, to produce non-alcohol chemicals from suitable carbon sources

Methodology Applied
Scientific EffectDecarboxylation:

Data Source

PatentUS9701948B2<i>Escherichia coli </i>engineered for isobutyraldehyde production
Publication Date: 2017.07.11 RGT UNIV OF CALIFORNIA
  • US9701948B2 patent drawing
  • US9701948B2 patent drawing
  • US9701948B2 patent drawing

AI summary

The present disclosure provides recombinant E. coli and other bacteria with reduced alcohol dehydrogenase and/or aldehyde reductase activity. The present disclosure further provides recombinant E. coli and other bacteria with reduced isobutyraldehyde reductase activity. Methods for the production and the uses of the recombinant bacteria are also provided. Specifically, recombinant bacteria further expressing 2-keto-acid decarboxylase can be used for producing higher aldehydes or other non-alcohol chemicals derived from aldehydes.